No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England

Vaccine

Volumn 29, Issue 14, 2011, Pages 2613-2618

  Pebody, Richard ^a   Andrews, Nick ^a   Waight, Pauline ^a   Malkani, Rashmi ^a   McCartney, Christine ^a   Ellis, Joanna ^a   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Pandemic; TIV effectiveness

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREGNANCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; VACCINATION; YOUNG ADULT;

EID: 79952222329     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.046     Document Type: Article

References (17)

1. Fleming D.M., Andrews N.J., Elllis J.S., Bermingham A., Sebastianpillai P., Elliot A.J., et al. Estimating Influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2009.
2. Skowronski D.M., De Serres G., Dickinson J., Petric M., Mak A., Fonseca K., et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009, 199(2):168-179.
3. Centers for Disease Control and Prevention. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morbidity and Mortality Weekly Report 2009; 58(17): 467-470.
4. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325(5937):197-201.
5. Kelly H., Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009, 14(31).
6. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. MMWR Morbidity and Mortality Weekly Report 2009; 58(44):1241-1245.
7. Kelly H., Barry S., Laurie K., Mercer G. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. Euro Surveill 2010, 15(47).
8. Garcia-Garcia L., Valdespino-Gomez J.L., Lazcano-Ponce E., Jimenez-Corona A., Higuera-Iglesias A., Cruz-Hervert P., et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009, case-control study in Mexico City. BMJ 2009, 339:b3928.
9. Echevarria-Zuno S., Mejia-Arangure J.M., Mar-Obeso A.J., Grajales-Muniz C., Robles-Perez E., Gonzalez-Leon M., et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009, 374(9707):2072-2079.
10. National Advisory Committee on Vaccination. Statement on seasonal trivalent inactivated influenza vaccine for 2009-10. Canada Communicable Disease Report 2009; 35.
11. Skowronski D.M., De Serres G., Crowcroft N.S., Janjua N.Z., Boulianne N., Hottes T.S., et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010, 7(4):e1000258.
12. Pebody R.G., Begum F., Gates P., Noakes K., Salisbury D. Influenza vaccination coverage in England, 2000-2008. Euro Surveill 2008, 13(51). pii: 19074.
13. Health Protection Agency Health Protection Scotland, National Public Health Service for Wales, HPA Northern Ireland Swine infleunza investigation teams. Epidemiology of new influenza A(H1N1) in the United Kingdom, April-May 2009. Euro Surveill 2009, 14.(19).
14. Ellis J., Iturriza M., Allen R., Bermingham A., Brown K., Gray J., et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Euro surveill 2009, 14(22). pii: 19230.
15. Curran M.D., Ellis J.S., Wreghitt T.G., Zambon M.C. Establishment of a UK national influenza H5 laboratory network. J Med Microbiol 2007, 56(Pt 10):1263-1267.
16. Bodewes R., Kreijtz J.H., Rimmelzwaan G.F. Yearly influenza vaccinations: a double-edged sword. Lancet Infect Dis 2009, 9(12):784-788.
17. Hoskins T.W., Davies J.R., Smith A.J., Allchin A., Miller C.L., Pollock T.M. Influenza at Christ's hospital: march, 1974. Lancet 1976, 1(7951):105-108.